selected publications
- Author Correction: Cancer cell metabolism and antitumour immunity. 2024 GET IT
- Cancer cell metabolism and antitumour immunity. Nature reviews. Immunology. 2024 Review GET IT
- Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer. 2023 GET IT
- Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma. Cancer letters. 2023 Academic Article GET IT
- Translating Science into Survival: Report on the Sixth International Cancer Immunotherapy Conference. Cancer immunology research. 2023 Academic Article GET IT
- Fatty acid metabolism and radiation-induced anti-tumor immunity. International review of cell and molecular biology. 2023 Review GET IT
- DNA damage repair kinase DNA-PK and cGAS synergize to induce cancer-related inflammation in glioblastoma. The EMBO journal. 2022 Academic Article GET IT
- Quantification of beta-galactosidase activity as a marker of radiation-driven cellular senescence. Methods in cell biology. 2022 Academic Article GET IT
-
Impact of Cryopreservation of Peripheral Blood Stem Cells (PBSC) in Transplantation from Matched Unrelated Donor (MUD).
Journal of clinical medicine.
2022
Academic Article
GET IT
Times cited: 9 - Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer. Cell death & disease. 2022 Academic Article GET IT
- ELISA-based quantification of type I IFN secretion by irradiated cancer cells. 2022 GET IT
-
Exploiting Radiation Therapy to Restore Immune Reactivity of Glioblastoma.
Frontiers in oncology.
2021
Information Resource
GET IT
Times cited: 14 -
Radiotherapy: An immune response modifier for immuno-oncology.
Seminars in immunology.
2021
Information Resource
GET IT
Times cited: 3 -
Activin A backs-up TGF-ß to promote regulatory T cells.
Oncoimmunology.
2021
Information Resource
GET IT
Times cited: 11 -
Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer.
Cancer immunology research.
2020
Academic Article
GET IT
Times cited: 51 -
Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth.
Oncogene.
2020
Academic Article
GET IT
Times cited: 1 -
Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy.
Oncoimmunology.
2020
Academic Article
GET IT
Times cited: 18 -
Apoptotic Caspases: A Double-Edged Sword in Radiation-Induced Immunogenicity.
Trends in cell biology.
2019
Article
GET IT
Times cited: 2 -
Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
BMC cancer.
2017
Academic Article
GET IT
Times cited: 25 -
TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2016
Academic Article
GET IT
Times cited: 37 -
Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth.
Molecular endocrinology (Baltimore, Md.).
2015
Academic Article
GET IT
Times cited: 12